Hosted on MSN1mon
Novo, Eli Lilly to dominate global pharma sales in 2025: reportBlockbuster weight loss medications from Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) lead Evaluate Pharma’s list of best-selling drugs projected for 2025 after the incretins pushed Bristol Myers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback